cbdMD has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, expanding the company’s consumer wellness platform beyond its traditional CBD and hemp businesses.
The proposed acquisition includes the Twinlab, Reserveage, Metabolife and Alvita Tea brands and is being conducted through an assignment for the benefit of creditors proceeding. The transaction remains subject to court approval and customary closing conditions.
Based on unaudited financial information, the combined businesses generated approximately $30 million in trailing 12-month revenue through June 2026, representing an increase of about 40% compared with cbdMD’s standalone revenue over the same period.
cbdMD said the incremental revenue is expected to make a positive contribution after transaction and integration costs. The acquisition is also expected to reduce cbdMD’s revenue concentration in hemp products and its exposure to the evolving regulatory environment surrounding hemp-derived products.
Founded in 1968, Twinlab has built a portfolio across vitamins, minerals, sports nutrition and active lifestyle products. Its products are distributed through approximately 50,000 retail outlets, including Vitamin Shoppe and GNC, along with a significant Amazon presence.
Reserveage focuses on longevity, resveratrol, collagen and beauty-from-within products, while Metabolife has established recognition in weight management. Twinlab’s broader portfolio also includes Rip Fuel in performance sports nutrition.
Following closing, cbdMD expects its broader platform to span supplements, sports nutrition, longevity, functional wellness, pet wellness, hemp-derived products and other consumer health categories.
The transaction follows cbdMD’s earlier acquisition and integration of Bluebird Botanicals and continues its strategy of building a collection of wellness brands supported by shared infrastructure, product development, ecommerce and operational capabilities.
cbdMD has filed a Form 8-K containing additional information about the transaction and closing conditions.
KEY QUOTES:
“Twinlab is the kind of brand equity that companies spend decades trying to build. The brands, distribution channels, and team are highly complementary to what we already operate, and this transaction gives these brands the stability and support they need for their next chapter. We believe there is a significant opportunity to build on cbdMD’s revenue growth by applying our marketing, creative, and ecommerce resources to drive brand awareness and expand direct-to-consumer sales, alongside the strong wholesale and retail presence these brands already have. From the fundamentals of nutrition to the frontier of modern wellness, the combined portfolio is a unique offering in consumer wellness.”
Ronan Kennedy, CEO of cbdMD
“cbdMD is the right home for these brands. Together, we will bring a uniquely complete wellness portfolio spanning foundational vitamins, minerals, and nutrition through botanicals, beauty, longevity, functional mushrooms, cannabinoids, and the emerging breakthroughs defining where this industry is headed. We believe no other company can serve consumers across more needs, more moments, and more stages of life than we now can together. This combination will pair decades of heritage and category credibility with a modern, marketing-driven platform and the resources to reintroduce these products to a new generation of consumers. It positions the brands, and the people behind them, for a strong future.”
Anthony Zolezzi, Chief Executive Officer of Twinlab
